Elite Pharma Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
03-2018 | 03-2017 | 03-2016 | 03-2015 | 03-2014 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 7,179 | 10,595 | 11,512 | 7,464 | 6,942 |
Receivables | 676 | 934 | 1,530 | 1,446 | 732 |
Inventories | 4,898 | 6,416 | 3,294 | 3,032 | 1,933 |
TOTAL | $13,702 | $18,413 | $16,714 | $12,331 | $9,925 |
Non-Current Assets | |||||
PPE Net | 8,994 | 9,039 | 8,111 | 6,402 | 4,200 |
Investments And Advances | 0 | 0 | 0 | 0 | 3,329 |
Intangibles | 7,713 | 6,419 | 6,412 | 6,382 | 6,350 |
Other Non-Current Assets | 474 | 440 | 438 | 806 | 514 |
TOTAL | $17,180 | $15,898 | $14,960 | $13,590 | $14,393 |
Total Assets | $30,883 | $34,311 | $31,674 | $25,920 | $24,318 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 655 | 487 | 549 | 475 | 3,404 |
Accounts payable and accrued liabilities | 1,658 | 1,050 | 1,804 | 3,384 | 2,215 |
Accrued Expenses | 1,789 | 795 | 555 | 614 | N/A |
TOTAL | $5,115 | $3,345 | $4,640 | $5,069 | $6,161 |
Non-Current Liabilities | |||||
Long Term Debt | 3,331 | 2,162 | 2,176 | 2,065 | 0 |
Deferred Revenues | 1,013 | 1,013 | 1,013 | 13 | 13 |
Other Non-Current Liabilities | 16,613 | 875 | 54,702 | 53,392 | 99,216 |
TOTAL | $21,196 | $5,302 | $60,156 | $55,582 | $99,355 |
Total Liabilities | $26,311 | $8,647 | $64,796 | $60,651 | $105,516 |
Shareholders' Equity | |||||
Shares Outstanding, K | 803,639 | 775,555 | 726,487 | 658,419 | 568,042 |
Common Shares | 803 | 928 | 712 | 631 | 560 |
Retained earnings | -142,527 | -138,854 | -142,665 | -141,982 | -225,007 |
Other shareholders' equity | -307 | -307 | -307 | -307 | -307 |
TOTAL | $4,572 | $25,664 | $-33,122 | $-34,731 | $-81,198 |
Total Liabilities And Equity | $30,883 | $34,311 | $31,674 | $25,920 | $24,318 |